| Category | Key Facts |
|---|---|
| Global Impact | - 3.5 lakh deaths annually due to cervical cancer (WHO, 2022). |
| - 90% of deaths occur in low- and middle-income countries (LMICs). | |
| WHO's 90-70-90 Targets | - 90% HPV vaccination, 70% screening, 90% treatment coverage. |
| Gavi's Achievement | - 86 million girls vaccinated by 2025 (target achieved ahead of schedule). |
| India's Cervical Cancer Burden | - Second most common cancer in women. |
| - 80,000+ cases reported in 2023-24. | |
| HPV Vaccine in India | - Not yet in Universal Immunisation Programme (UIP). |
| - Limited rollout in Sikkim & Bihar. | |
| - Phased introduction planned (Budget 2024). | |
| NTAGI Recommendation | - Vaccinate girls aged 9-14 years. |
| AIIMS Innovation | - ₹100 cervical cancer test kit with 2-hour results. |
| Vaccine Efficacy | - 90% protection if administered before sexual activity. |
| - Prevents 17.4 deaths per 1,000 children vaccinated (WHO). | |
| Challenges in India | - Low awareness, affordability issues, infrastructure gaps. |
Workflow
Login
Contact Counsellor